Company logo

NNOX - Nano-X Imaging Ltd.

NASDAQ -> Healthcare -> Medical Devices
Neve Ilan, Israel
Type: Equity

NNOX price evolution
NNOX
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $66.38 $42 $37.57 $38.46
Short term investments $28.61 $32.47 $40.52 $39.16
Net receivables $1.16 $1.43 $1.31 $0.98
Inventory
Total current assets $97.62 $77.52 $81.86 $82.46
Long term investments $0.6 $5.88 $12.88 $25.26
Property, plant & equipment $48.07 $46.45 $46.59 $44.7
Goodwill & intangible assets $83.26 $93.33 $95.99 $98.64
Total noncurrent assets $133.69 $147.37 $157.11 $171.47
Total investments $29.21 $38.35 $53.4 $64.42
Total assets $231.31 $224.88 $238.97 $253.93
Current liabilities
Accounts payable $1.63 $3.97 $3.72 $3.62
Deferred revenue $0.52 $0.58 $0.47 $0.58
Short long term debt $0.6 $0.45 $0.59 $0.74
Total current liabilities $20.04 $23.43 $24.17 $25.07
Long term debt $5.63 $4.21 $4.32 $3.88
Total noncurrent liabilities $9.24 $7.92 $8.07 $12.18
Total debt $6.24 $4.66 $4.91 $4.62
Total liabilities $29.28 $31.35 $32.23 $37.25
Shareholders' equity
Retained earnings -$309.99 -$288.58 -$271.22 -$259.46
Other shareholder equity -$0.65 -$1.01 -$1.38 -$1.97
Total shareholder equity $202.03 $193.53 $206.73 $216.68
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $38.46 $66.64 $213.47 $8.07
Short term investments $39.16 $22.07
Net receivables $0.98 $1.05
Inventory
Total current assets $82.46 $94.86 $219.79 $9.64
Long term investments $25.26 $67.97 $0.32 $0.14
Property, plant & equipment $44.7 $39.16 $15.38 $0.75
Goodwill & intangible assets $98.64 $160.12
Total noncurrent assets $171.47 $268.31 $16.36 $2.23
Total investments $64.42 $90.04 $0.32 $0.14
Total assets $253.93 $363.17 $236.15 $11.87
Current liabilities
Accounts payable $3.62 $3.13 $0.43 $0.47
Deferred revenue $0.58 $0.66
Short long term debt $0.74 $1.03 $0.52 $0.14
Total current liabilities $25.07 $52.75 $4.48 $20.26
Long term debt $3.88 $4.75 $0.92 $0.39
Total noncurrent liabilities $12.18 $18.27 $0.92 $0.39
Total debt $4.62 $5.77 $1.44 $0.53
Total liabilities $37.25 $71.02 $5.4 $20.65
Shareholders' equity
Retained earnings -$259.46 -$146.21 -$84.42 -$40.6
Other shareholder equity -$1.97 -$0.61
Total shareholder equity $216.68 $292.15 $230.75 -$8.78
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $2.48 $2.58 $2.45 $2.13
Cost of revenue $4.14 $4.27 $3.97 $3.88
Gross Profit -$1.66 -$1.69 -$1.52 -$1.75
Operating activities
Research & development $6.04 $6.91 $6.29 $7.09
Selling, general & administrative $6.19 $8.46 $8.96 $9.68
Total operating expenses $20.33 $16.14 $10.55 $52.01
Operating income -$21.99 -$17.83 -$12.08 -$53.76
Income from continuing operations
EBIT -$21.48 -$17.45 -$11.86 -$53.76
Income tax expense -$0.08 -$0.09 -$0.09 -$1.03
Interest expense $0.11
Net income
Net income -$21.4 -$17.36 -$11.76 -$52.84
Income (for common shares) -$21.4 -$17.36 -$11.76 -$52.84
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $8.58 $1.3
Cost of revenue $15.46 $2.82
Gross Profit -$6.88 -$1.51
Operating activities
Research & development $26.51 $17.12 $9.21 $2.72
Selling, general & administrative $45.63 $41.74 $34.71 $19.85
Total operating expenses $110.83 $60.05 $43.92 $22.57
Operating income -$117.71 -$61.56 -$43.92 -$22.57
Income from continuing operations
EBIT -$117.71 -$61.56 -$43.92 -$22.57
Income tax expense -$3.68 -$0.05
Interest expense -$0.79 $0.29 -$0.11 -$0.01
Net income
Net income -$113.24 -$61.8 -$43.81 -$22.56
Income (for common shares) -$113.24 -$61.8 -$43.81 -$22.56
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$21.4 -$17.36 -$11.76 -$44.84
Operating activities
Depreciation $2.9 $2.91 $2.91 $2.93
Business acquisitions & disposals
Stock-based compensation $2.12 $1.82 $1.04 $2.28
Total cash flows from operations -$11.47 -$10.11 -$10.67 -$12.88
Investing activities
Capital expenditures -$0.94 -$0.34 -$1.5 $0.22
Investments $9.61 $15.22 $11.11 $10.89
Total cash flows from investing $8.67 $14.87 $9.62 $11.11
Financing activities
Dividends paid
Sale and purchase of stock $27.41 $0.42 $0.18 $0.32
Net borrowings -$0.14
Total cash flows from financing $27.41 -$0.37 $0.18 $0.17
Effect of exchange rate $0.07 $0.04 -$0.01 -$0.27
Change in cash and equivalents $24.68 $4.42 -$0.89 -$1.87
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$105.24 -$61.8 -$43.81 -$22.56
Operating activities
Depreciation $11.51 $0.21 $0.05
Business acquisitions & disposals
Stock-based compensation $18.62 $24.78 $16.25
Total cash flows from operations -$43.38 -$21.49 -$5.52
Investing activities
Capital expenditures -$7.17 -$13.94 -$0.13
Investments $21.78
Total cash flows from investing $14.61 -$13.94 -$0.13
Financing activities
Dividends paid
Sale and purchase of stock $0.95 $240.99 $14.2
Net borrowings -$0.14
Total cash flows from financing $0.8 $240.99 $13.86
Effect of exchange rate -$0.27
Change in cash and equivalents -$28.24 $205.57 $8.21
Fundamentals
Market cap $570.27M
Enterprise value $510.13M
Shares outstanding 57.72M
Revenue $9.64M
EBITDA -$92.90M
EBIT -$104.54M
Net Income -$103.36M
Revenue Q/Q 1.68%
Revenue Y/Y N/A
P/E ratio -5.52
EV/Sales 52.92
EV/EBITDA -5.49
EV/EBIT -4.88
P/S ratio 59.16
P/B ratio 2.81
Book/Share 3.51
Cash/Share 1.15
EPS -$1.79
ROA -43.56%
ROE -50.48%
Debt/Equity 0.17
Net debt/EBITDA 0.40
Current ratio 4.87
Quick ratio 4.87